Development of a Point-of-Care Diagnostic for Influenza Detection with Antiviral Treatment Effectiveness Indication
The ability to rapidly determine if a patient has an infectious disease and what type of treatment the infection will respond to, would significantly reduce the treatment decision time, shorten the impact of symptoms, and minimize transfer to others.
Cardiac Point of Care – Current Technology and Future Directions
Paul Collinson, St Georges Healthcare NHS Trust, speaking at Point of Care Diagnostics 2015
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends
This presentation will outline key issues in oncology biomarker testing and describe findings from a study of practices used by National Cancer Institute (NCI) designated cancer centers, the leading U.S. oncology institutions, for testing key biomarkers in three solid tumors - breast, gastroesophageal and non-small cell lung cancers.
Novel Chip-based Extraction of miRNA
The chip-system is capable of extracting miRNAs from tumor cell cultures, fresh frozen cells and archive material samples by on-chip gel electrophoresis.
Highly-integrated Lab-on-a-chip System for Multiparameter Analysis at the Point-of-care
A lab-on-a-chip system called the "Fraunhofer ivD-platform" has been established which opens up the possibility for an on-site analysis at low costs.
Advanced Centrifugal Microfluidics for Point-of-Care Applications
Centrifugal microfluidics enables efficient miniaturization, integration, parallelization and automation of biochemical assays especially for Point-of-Care applications.
The Application of a Resonant Coil Magnetometer for Point of Care Diagnostic Applications
Richard Luxton, University of the West of England, speaking at Point of Care Diagnostics 2015
Imaging Biomarkers - Future or Reality
Imaging has been at the heart of Medicine for many decades. However, its influence is changing as the need increases not only for diagnosis of disease, but also for quantification of disease extent, identification of suitable candidates for treatment and for testing of both treatment response or assessment of potential side effects for new treatments.
Genome-Scale Protein Expression Analysis of Individual Solid Tumors
Present diagnostic procedures and therapeutic strategies solid tumours rely on the detection and targeting of specific marker molecules to classify the tumour and to design an efficient therapy.
Tissue and cfDNA Rare Alleles How Low Can We Go
Seth Crosby, Washington University School of Medicine, discusses both bench and informatic methods used to increase specificity in the apprehension of rare cfDNA alleles.